Safety and Efficacy of ZVS101e in Patients With Bietti 's Crystalline Dystrophy
Status:
Recruiting
Trial end date:
2028-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the safety and efficacy of ZVS101e administered by
subretinal injection in subjects with Bietti's crystalline dystrophy (BCD) and to select the
optimal effective dose.